Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: Preliminary results of an open French multicentre randomized study
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27, S18-S21
- https://doi.org/10.1016/0277-5379(91)90558-u
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaAmerican Journal Of Medicine, 1990
- Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationBlood, 1988
- Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2bInvestigational New Drugs, 1987
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalBlood, 1985
- PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCERThe Lancet, 1985
- Prognostic discrimination in "good-risk" chronic granulocytic leukemiaBlood, 1984
- Staging of Chronic Myeloid LeukaemiaBritish Journal of Haematology, 1981